Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299182
Status:
COMPLETED
Last Update Posted:
2021-09-21
First Post:
2006-03-03
Brief Title:
Study of AMG 531 to Evaluate the Safety Efficacy in Patients With Non-Hodgkins Lymphoma
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| Cytosine arabinosine hydrochloride | View |
| Non-Hodgkins Lymphoma | View |
| Lymphoma | View |
| Mantle Cell Lymphoma | View |
| AMG 531 | View |
| Romiplostim | View |
| Placebo | View |
| R-HyperCVAD | View |
| R-Ara-CMTX | View |
| Cyclophosphamide | View |
| Cytarabine | View |
| Dexamethasone | View |
| Doxorubicin | View |
| Methotrexate | View |
| Rituximab | View |
| Vincristine | View |
| Decadron | View |
| Neosar | View |
| AD | View |
| Hydroxydaunomycin hydrocholoride | View |
| Ara-C | View |
| Cytosar | View |
| DepoCyt | View |